Excess Re-intervention with Mitroflow Prosthesis for AVR: Ten-year Outcomes of a Randomized Trial

CONCLUSIONS: The Magna valve had the lowest gradients and largest AVAi with larger implant sizes. The Mitroflow bioprosthesis is associated with increased rate of re-intervention and possible increased risk of infection compared to Magna and Epic valves.PMID:36183748 | DOI:10.1016/j.athoracsur.2022.09.031

Source: The Annals of Thoracic Surgery - October 2, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Busra Cangut Hartzell V Schaff Rakesh M Suri Kevin L Greason John M Stulak Brian D Lahr Hector I Michelena Richard C Daly Joseph A Dearani Juan A Crestanello Source Type: research